| Cash flow (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | -10.50B | 2.02B | 2.18B | 3.05B | 1.96B | 1.31B | 1.78B | 1.25B |
| Depreciation and amortization | 98.00M | 93.00M | 90.00M | 90.00M | 93.00M | 97.00M | 95.00M | 94.00M |
| Stock-based compensation | 231.00M | 218.00M | 230.00M | 230.00M | 225.00M | 209.00M | 222.00M | 216.00M |
| Cash from operations | 3.57B | 2.54B | 3.33B | 4.11B | 827.00M | 1.76B | 2.98B | 4.31B |
| Capital expenditure | -140.00M | -117.00M | -205.00M | -147.00M | -107.00M | -104.00M | -147.00M | -141.00M |
| Free cash flow | 3.43B | 2.43B | 3.12B | 3.96B | 720.00M | 1.65B | 2.83B | 4.17B |
| Acquisitions | -11.21B | -109.00M | -609.00M | -167.00M | -21.00M | -273.00M | -75.00M | -570.00M |
| Cash from investing | -10.35B | 1.77B | -1.83B | -427.00M | -2.12B | -415.00M | -225.00M | -710.00M |
| Dividends paid | -1.03B | -1.04B | -994.00M | -1.00B | -994.00M | -1.01B | -973.00M | -983.00M |
| Share buybacks | -355.00M | -419.00M | -230.00M | -435.00M | -527.00M | -730.00M | -350.00M | -300.00M |
| Net debt issued | -17.00M | -2.77B | -8.00M | -9.00M | -9.00M | -1.76B | -7.00M | -112.00M |
| Cash from financing | 2.34B | -4.24B | -1.26B | -1.49B | -1.57B | -3.43B | 2.26B | -1.38B |
| Net change in cash | -4.45B | 65.00M | 233.00M | 2.19B | -2.78B | -2.06B | 4.96B | 2.26B |
From Gilead Sciences's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.